STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1043 by analyst upside · 2026-06-27
WHWK
Whitehawk Therapeutics, Inc.
Healthcare · Market Cap $206M · P/E 0x
ANALYST PRICE TARGET
+73.1%
implied upside to consensus target
Current Price $4.16
Consensus Target $7.2
Bull Target $10.0
Bear Target $4.0
Analysts Covering 5
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
2
Hold
3
Sell
0
52-Week Low $1.57
52-Week High $5.5
YTD Return +70.5%
FUNDAMENTALS
Market Cap $206M
P/E Ratio (TTM) N/A
Forward P/E -3.6x
EPS (TTM) $-2.53
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.57
52-Week High $5.5
Current Price $4.16
Bear Target $4.0
Bull Target $10.0
● Now $4.16 ● Target $7.2
TRADING DATA
Avg Volume 398K
YTD Return +70.5%
Analyst Count 5
Consensus Hold
Upside to Target +73.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Whitehawk Therapeutics, Inc. (WHWK) is currently trading at $4.16 with a Wall Street consensus price target of $7.2, implying potential upside of 73.1% over the next 12 months. 5 analysts currently cover WHWK, with a consensus rating of Hold - 40% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $10.0, while the most cautious has a target of $4.0.

WHWK operates in the Healthcare sector with a market capitalisation of $206M. The stock is up 70.5% year-to-date and is currently trading near the upper end of its 52-week range of $1.57 – $5.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for WHWK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citizens ● Initiated
Market Outperform 2026-04-16 Building track record
Jones Trading ● Initiated
Buy 2025-12-22 57% win rate (14 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
22
out of 100
Coverage depth
14/30
Consensus clarity
1/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →